These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6748579)

  • 21. Study of iron metabolism abnormality in the hepatocyte damage of hepatitis B.
    Cao Z; Bai Y; Yang X; Liu J; Li B; Li F
    Zhonghua Gan Zang Bing Za Zhi; 2001 Feb; 9(1):37-9. PubMed ID: 11242134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic iron excess.
    Balcerzak SP
    Med Times; 1969 Jul; 97(7):114-29. PubMed ID: 5787906
    [No Abstract]   [Full Text] [Related]  

  • 23. Severe hemosiderosis post allogenic bone marrow transplantation.
    Mahendra P; Hood IM; Bass G; Patterson P; Marcus RE
    Hematol Oncol; 1996 Mar; 14(1):33-5. PubMed ID: 8613134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disturbances of iron metabolism in chronic liver diseases.
    Sikorska K; Stalke P; Lakomy EA; Michalska Z; Witczak-Malinowska K; Stolarczyk J
    Med Sci Monit; 2003 Aug; 9 Suppl 3():64-7. PubMed ID: 15156616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variant liver estrogen receptor transcripts already occur at an early stage of chronic liver disease.
    Villa E; Dugani A; Moles A; Camellini L; Grottola A; Buttafoco P; Merighi A; Ferretti I; Esposito P; Miglioli L; Bagni A; Troisi R; De Hemptinne B; Praet M; Callea F; Manenti F
    Hepatology; 1998 Apr; 27(4):983-8. PubMed ID: 9537437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of the liver.
    Mazza P; Giua R; De Marco S; Bonetti MG; Amurri B; Masi C; Lazzari G; Rizzo C; Cervellera M; Peluso A
    Haematologica; 1995; 80(5):398-404. PubMed ID: 8566878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A case of hypersiderosis. The long-term iron supplement in uremic patients treated with periodic dialysis].
    Lusvarghi E; Lamperi S
    Minerva Nefrol; 1982; 29(2):71-83. PubMed ID: 7133542
    [No Abstract]   [Full Text] [Related]  

  • 28. Additional effect of low iron diet on iron reduction therapy by phlebotomy for chronic hepatitis C.
    Kimura F; Hayashi H; Yano M; Yoshioka K; Matsumura T; Fukuda T; Shigeto N; Yamahara S; Koushi F; Mishima Y; Yoshino T; Tanimoto M; Kimura I
    Hepatogastroenterology; 2005; 52(62):563-6. PubMed ID: 15816478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrahepatic expression of c-fos, c-myb and c-myc oncogenes: correlation with virus-induced chronic liver disease and response to interferon.
    Tappero G; Farina M; Negro F; Anfossi G; Mattiello L; Giuli PD; Colombatto P; Brunetto MR; Angeli A; Bonino F
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):148-54. PubMed ID: 9646196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Iron-overload in patients on maintenance hemodialysis: diagnostic criteria, indications and treatment by desferrioxamine (author's transl)].
    Simon P; Bonn F; Guezennec M; Tanquerel T; Ksang
    Nephrologie; 1981; 2(4):165-70. PubMed ID: 7329501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soluble transferrin receptor-ferritin index and estimated body iron in iron-deficiency anemia in "select" chronic diseases.
    Park G; Park CY; Jang SJ; Moon DS; Park SM; Park YJ
    Ann Hematol; 2009 Sep; 88(9):913-5. PubMed ID: 19137299
    [No Abstract]   [Full Text] [Related]  

  • 32. Iron and porphyria cutanea tarda.
    D'Alessandro Gandolfo L; Griso D; Macrì A; Biolcati G; Barlattani A; Topi GC
    Cell Mol Biol (Noisy-le-grand); 1997 Feb; 43(1):75-9. PubMed ID: 9074791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C.
    Sebastiani G; Vario A; Ferrari A; Pistis R; Noventa F; Alberti A
    J Viral Hepat; 2006 Mar; 13(3):199-205. PubMed ID: 16475996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iron overload and liver dysfunction after allogeneic or autologous bone marrow transplantation.
    McKay PJ; Murphy JA; Cameron S; Burnett AK; Campbell M; Tansey P; Franklin IM
    Bone Marrow Transplant; 1996 Jan; 17(1):63-6. PubMed ID: 8673057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prostaglandins and collagen metabolism in chronic liver diseases].
    Iagoda AV; Topchieva GIu; Geĭvandova NI; Markova IV
    Klin Med (Mosk); 1993; 71(3):51-5. PubMed ID: 8015221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative action of fangotherapeutic procedures and inductotherapy on certain indicators of metabolism in patients with severe forms of chronic hepatitis at the Druskininkaĭ health resort].
    Pavalkis VIa
    Vopr Kurortol Fizioter Lech Fiz Kult; 1974; (5):436-9. PubMed ID: 4548601
    [No Abstract]   [Full Text] [Related]  

  • 37. Role of transferrin receptor 2 in hepatic accumulation of iron in patients with chronic hepatitis C.
    Mifuji R; Kobayashi Y; Ma N; Qiang QL; Urawa N; Horiike S; Iwasa M; Kaito M; Malavasi F; Adachi Y
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):144-51. PubMed ID: 16706826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of iron status in patients with chronic hepatitis C.
    Sartori M; Andorno S; La Terra G; Boldorini R; Leone F; Pittau S; Zecchina G; Aglietta M; Saglio G
    Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):396-401. PubMed ID: 9789136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Iron metabolism in chronic vascular-related purpura diseases].
    Kozlowski J; Szyszymár B; Wankiewicz R
    Dermatol Wochenschr; 1967 Oct; 153(42):1166-72. PubMed ID: 5607691
    [No Abstract]   [Full Text] [Related]  

  • 40. Epidemiological characteristics of HBV and HDV chronic liver diseases.
    Jelić D; Jelić O
    Acta Med Croatica; 1994; 48(1):7-13. PubMed ID: 7519496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.